|
201
|
|
|
Cholinergic receptor nicotinic alpha 5 subunit |
LNCR2 |
Anxiety disorder, Atherosclerosis, Autism, Bipolar disorder, Bronchus cancer, Chronic bronchitis, Lung disease, Obstructive airway disease, Obstructive pulmonary disease, Dental caries, Emphysema, Gout, Lung cancer, Lung neoplasms, Non-small cell lung carcinoma, Peripheral vascular disease, Respiratory system cancer, Respiratory system disease, Schizophrenia, Seizures, Small cell lung carcinoma, Squamous cell carcinoma, Substance abuse, Upper aerodigestive tract neoplasm, Vascular diseaseView all (10 more) |
|
202
|
|
|
Cholinergic receptor nicotinic alpha 7 subunit |
CHRNA7-2, NACHRA7, nAChR7 |
15q13.3 microdeletion syndrome, Alzheimer disease, Auditory perceptual disorder, Autism, Bipolar disorder, Brain injuries, Obstructive airway disease, Neurodevelopmental disorder, Congenital omphalocele, Epilepsy, Generalized epilepsy, Intellectual developmental disorder, Lung neoplasms, Memory disorders, Non-specific syndromic intellectual disability, Orofacial cleft, Schizophrenia, Seizures, Substance abuseView all (4 more) |
|
203
|
|
|
Cholinergic receptor nicotinic beta 1 subunit |
ACHRB, CHRNB, CMS1D, CMS2A, CMS2C, SCCMS |
|
|
204
|
|
|
Cholinergic receptor nicotinic beta 2 subunit |
EFNL3, nAChRB2 |
Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Nocturnal frontal lobe epilepsy, Colorectal cancer, Frontal lobe epilepsy, Focal onset epileptic seizure, Seizure, Neutropenia, Schizophrenia, Substance abuse |
|
205
|
|
|
Cholinergic receptor nicotinic beta 3 subunit |
- |
|
|
206
|
|
|
Cholinergic receptor nicotinic beta 4 subunit |
- |
Amyotrophic lateral sclerosis, Aneurysm, Aortic stenosis, Aortic valve disease, Obstructive airway disease, Obstructive pulmonary disease, Coronary artery disease, Dental caries, Frontotemporal dementia, Hypertrophic cardiomyopathy, Large artery stroke, Lung cancer, Lung neoplasms, Obesity, Obsessive-compulsive disorder, Peripheral arterial disease, Rolandic epilepsy, Schizophrenia, Seizures, Small cell lung carcinoma, Squamous cell carcinoma, Substance abuse, Upper aerodigestive tract neoplasmView all (8 more) |
|
207
|
|
|
Cholinergic receptor nicotinic delta subunit |
ACHRD, CMS2A, CMS3A, CMS3B, CMS3C, FCCMS, SCCMS |
|
|
208
|
|
|
Cholinergic receptor nicotinic epsilon subunit |
ACHRE, CMS1A1, CMS1D, CMS1E, CMS2A, CMS4A, CMS4B, CMS4C, FCCMS, FIM1, FIMG, FIMG1, MGI, SCCMS |
|
|
209
|
|
|
Cholinergic receptor nicotinic gamma subunit |
ACHRG |
|
|
210
|
|
|
Component of inhibitor of nuclear factor kappa B kinase complex |
BPS2, IKBKA, IKK-1, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 |
Anorexia nervosa, Attention deficit hyperactivity disorder, Autism, Bartsocas-papas syndrome, Bone disease, Combined immunodeficiency-hypogammaglobulinemia-skeletal anomalies syndrome due to ikbka deficiency, Congenital skin anomaly, Congenital anomaly of limb, Skin abnormalitie, Squamous cell carcinoma, Diabetes mellitus, type 2 |